Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Morgan Stanley (NYSE: MS) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures, including current reports on Form 8‑K and other registered securities information. These filings show how Morgan Stanley communicates material events such as quarterly and annual financial results, capital actions, regulatory capital developments and securities offerings.
Form 8‑K filings frequently cover the release of financial information for specific quarters and for the full year, with press releases and financial data supplements filed as exhibits. Other 8‑K reports describe changes in the firm’s Stress Capital Buffer under the Federal Reserve’s supervisory stress testing framework, providing context on Morgan Stanley’s U.S. Basel III Standardized Approach Common Equity Tier 1 capital requirements.
The filings also list the securities registered under Section 12(b) of the Securities Exchange Act of 1934, including common stock, multiple series of non‑cumulative preferred stock represented by depositary shares, and global medium‑term notes issued by Morgan Stanley or Morgan Stanley Finance LLC, with Morgan Stanley acting as guarantor for certain notes. Additional 8‑K filings describe the approval of forms of master notes for global medium‑term notes and related legal opinions and consents.
On Stock Titan, these SEC documents are updated as they are made available on EDGAR. AI‑powered summaries help explain the key points in lengthy filings, so users can quickly see what each 8‑K, 10‑K or 10‑Q addresses without reading every page. Investors can also use this page to monitor registered securities, preferred stock disclosures and other regulatory information related to Morgan Stanley.
Morgan Stanley Finance LLC has announced Buffered PLUS (Performance Leveraged Upside Securities) due June 28, 2030, with an aggregate principal amount of $4,592,000. These structured investments are based on the performance of the S&P 500® Futures Excess Return Index and are fully guaranteed by Morgan Stanley.
Key features include:
- Issue price of $1,000 per security with an estimated value of $959.00
- 160.25% leverage factor for upside participation
- 30% downside buffer protection
- No periodic interest payments
- Three payout scenarios at maturity based on final index level performance
The securities offer leveraged upside potential if the index appreciates, full principal protection if the index declines up to 30%, and loss exposure of 1% for every 1% decline beyond the buffer level. The estimated value reflects costs associated with issuing, selling, structuring, and hedging, resulting in a value lower than the issue price. These securities involve significant risks and are not FDIC insured.
Morgan Stanley Finance LLC has issued $814,000 in Trigger PLUS (Performance Leveraged Upside Securities) due June 28, 2030, fully guaranteed by Morgan Stanley. These structured investments are linked to the worst-performing of three major indices: EURO STOXX 50, Nasdaq-100, and Dow Jones Industrial Average.
Key terms of the securities:
- Issue price: $1,000 per security with estimated value of $945.10
- Payment at maturity depends on performance of worst-performing index
- Offers 252% leveraged upside if all indices exceed initial levels
- Principal protection only if all indices stay above 65% threshold
- Risk of total loss if any index falls below threshold
Notable risks include no guaranteed principal return, no interest payments, and exposure to credit risk of Morgan Stanley. The securities are not listed on any exchange and involve complex terms that may result in significant losses based on the performance of any single underlying index.
Morgan Stanley Finance has announced Contingent Income Memory Buffered Auto-Callable Securities linked to the S&P U.S. Equity Momentum 40% VT 4% Decrement Index (SPUMP40), due August 1, 2030. Key features include:
- Contingent Coupon Rate: 9.00% to 10.00% per annum with memory feature
- Auto-Call Feature: Monthly redemption after 1 year if index closes at or above 100% of initial level
- Downside Protection: 15% buffer against losses (85% maximum loss)
- Coupon Barrier: 60% of initial level
The securities, priced at an estimated value of $898.00 per unit, offer conditional monthly income with partial principal protection. Key risks include early redemption risk, credit risk of Morgan Stanley, and the limited upside potential as investors won't participate in index appreciation. The underlier's 4% decrement feature and limited operating history (established March 2022) present additional investment considerations.
Morgan Stanley (NYSE: MS) filed a routine 424B2 prospectus supplement for the issuance of $998,000 in Dual Directional Buffered Participation Securities due June 28, 2030, fully and unconditionally guaranteed by Morgan Stanley.
The notes are principal-at-risk, pay no periodic interest, and are linked to the S&P 500 Index. At maturity investors may receive: (i) up to 154.50% of principal if the index rises, capped at a $1,545 maximum payment per $1,000 note; (ii) up to a 20% positive return if the index falls up to 20%; or (iii) a dollar-for-dollar loss beyond a 20% buffer, subject to a $200 minimum payment. The estimated value on the pricing date is $948.80 per note, reflecting upfront selling and hedging costs and an internal funding rate that favors the issuer. MS&Co. will receive a fixed $40 sales commission per security and may make a secondary market but is not obligated to do so.
The total size of the offering is immaterial to Morgan Stanley’s balance sheet and no new financial results, strategic changes, or risk factors specific to the firm were disclosed. Accordingly, the filing is considered a standard shelf-registered structured note issuance rather than a material corporate event.
Morgan Stanley Finance has issued $3.8M in Buffered Performance Leveraged Upside Securities (Buffered PLUS) due June 30, 2027, linked to the worst-performing of the Dow Jones Industrial Average and S&P 500 Index. The securities are fully guaranteed by Morgan Stanley.
Key features include:
- Issue price: $1,000 per security with estimated value of $968.90
- 150% leverage factor on upside performance, capped at maximum payment of 120.58% of principal
- 15% downside buffer - principal protected against first 15% decline
- Below buffer level, investors lose 1% for every 1% decline in worst-performing index
- No periodic interest payments
The securities involve significant risks including potential loss of principal, limited upside due to the cap, and exposure to the worst-performing of two indices. Payment at maturity depends solely on the performance of the worst-performing underlying index on the observation date of June 25, 2027.
Morgan Stanley Finance has issued $100,000 in Contingent Income Memory Buffered Auto-Callable Securities due June 28, 2030, linked to the S&P 500 Futures 40% Intraday 4% Decrement VT Index. Key features include:
- Contingent Coupon: 9.50% annual rate, paid only if the index closes at or above 60% of initial level (1,409.904)
- Auto-Call Feature: Securities automatically redeem if index closes at or above initial level (2,349.84) on any redemption date starting June 25, 2026
- Principal Protection: 85% buffer level (1,997.364); losses begin below this threshold
- Pricing: $1,000 per security with estimated value of $904.30
The securities are unsecured obligations of Morgan Stanley Finance, fully guaranteed by Morgan Stanley. Investors face potential loss of principal if the index falls below buffer level, with minimum payment at maturity of 15% of principal. The offering includes memory feature for unpaid coupons and no participation in index appreciation.
Morgan Stanley Finance has issued Contingent Income Auto-Callable Securities tied to UnitedHealth Group stock, due July 7, 2028. These structured notes offer a potential 15.50% annual contingent coupon payable if UnitedHealth's stock closes at or above the 70% coupon barrier level on observation dates.
Key features include:
- Automatic early redemption if stock closes at or above initial level on redemption dates
- Principal protection at maturity if stock stays above 70% of initial level
- Principal at risk with 1:1 downside exposure if stock falls below 70% threshold
- Estimated value of $955.40 per $1,000 security
The securities are unsecured obligations of Morgan Stanley Finance, guaranteed by Morgan Stanley. Investors face full principal risk and may receive no coupons if the stock performs poorly. The first possible early redemption date is January 2, 2026.